Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study
We assessed the therapeutic potential of riociguat, a novel soluble guanylate cyclase stimulator, in adults with chronic thromboembolic pulmonary hypertension (CTEPH; n = 42) or pulmonary arterial hypertension (PAH; n = 33) in World Health Organization (WHO) functional class II/III. - In this 12-wee...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
June 07 2010
|
| In: |
The European respiratory journal
Year: 2010, Jahrgang: 36, Heft: 4, Pages: 792-799 |
| ISSN: | 1399-3003 |
| DOI: | 10.1183/09031936.00182909 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1183/09031936.00182909 Verlag, lizenzpflichtig, Volltext: https://erj.ersjournals.com/content/36/4/792 
|
| Verfasserangaben: | H.A. Ghofrani, M.M. Hoeper, M. Halank, F.J. Meyer, G. Staehler, J. Behr, R. Ewert, G. Weimann and F. Grimminger, on behalf of the study investigators |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1838485767 | ||
| 003 | DE-627 | ||
| 005 | 20230710153545.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230307s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1183/09031936.00182909 |2 doi | |
| 035 | |a (DE-627)1838485767 | ||
| 035 | |a (DE-599)KXP1838485767 | ||
| 035 | |a (OCoLC)1389821195 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ghofrani, Hossein Ardeschir |d 1967- |e VerfasserIn |0 (DE-588)120657686 |0 (DE-627)08081154X |0 (DE-576)292326254 |4 aut | |
| 245 | 1 | 0 | |a Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension |b a phase II study |c H.A. Ghofrani, M.M. Hoeper, M. Halank, F.J. Meyer, G. Staehler, J. Behr, R. Ewert, G. Weimann and F. Grimminger, on behalf of the study investigators |
| 264 | 1 | |c June 07 2010 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 07.03.2023 | ||
| 520 | |a We assessed the therapeutic potential of riociguat, a novel soluble guanylate cyclase stimulator, in adults with chronic thromboembolic pulmonary hypertension (CTEPH; n = 42) or pulmonary arterial hypertension (PAH; n = 33) in World Health Organization (WHO) functional class II/III. - In this 12-week, multicentre, open-label, uncontrolled phase II study, patients received oral riociguat 1.0-2.5 mg t.i.d. titrated according to systemic systolic blood pressure (SBP). Primary end-points were safety and tolerability; pharmacodynamic changes were secondary end-points. - Riociguat was generally well tolerated. Asymptomatic hypotension (SBP <90 mmHg) occurred in 11 patients, but blood pressure normalised without dose alteration in nine and after dose reduction in two. Median 6-min walking distance increased in patients with CTEPH (55.0 m from baseline (390 m); p<0.0001) and PAH (57.0 m from baseline (337 m); p<0.0001); patients in functional class II or III and bosentan pre-treated patients showed similar improvements. Pulmonary vascular resistance was significantly reduced by 215 dyn·s·cm−5 from baseline (709 dyn·s·cm−5; p<0.0001). 42 (56%) patients were considered to have experienced drug-related adverse events (AEs; 96% mild or moderate). Dyspepsia, headache and hypotension were the most frequent AEs. Study discontinuation because of AEs was 4%. - These preliminary data show that riociguat has a favourable safety profile and improves exercise capacity, symptoms and pulmonary haemodynamics in CTEPH and PAH. Randomised controlled trials are underway. | ||
| 650 | 4 | |a Chronic thromboembolic pulmonary hypertension | |
| 650 | 4 | |a clinical study | |
| 650 | 4 | |a phase II | |
| 650 | 4 | |a pulmonary arterial hypertension | |
| 650 | 4 | |a riociguat | |
| 650 | 4 | |a soluble guanylyl cyclase | |
| 700 | 1 | |a Höper, Marius |d 1963- |e VerfasserIn |0 (DE-588)130336408 |0 (DE-627)498447251 |0 (DE-576)298134691 |4 aut | |
| 700 | 1 | |a Halank, Michael |e VerfasserIn |0 (DE-588)138667144 |0 (DE-627)604889720 |0 (DE-576)308517369 |4 aut | |
| 700 | 1 | |a Meyer, Franz Joachim |d 1965- |e VerfasserIn |0 (DE-588)114011516 |0 (DE-627)577155490 |0 (DE-576)289782686 |4 aut | |
| 700 | 1 | |a Stähler, Gerd |e VerfasserIn |0 (DE-588)1252846037 |0 (DE-627)1794631720 |4 aut | |
| 700 | 1 | |a Behr, J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ewert, Ralf |d 1960- |e VerfasserIn |0 (DE-588)138823987 |0 (DE-627)606152520 |0 (DE-576)309256763 |4 aut | |
| 700 | 1 | |a Weimann, G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Grimminger, Friedrich |e VerfasserIn |0 (DE-588)112910629 |0 (DE-627)663356237 |0 (DE-576)346511135 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The European respiratory journal |d Lausanne : ERS, 1988 |g 36(2010), 4, Seite 792-799 |h Online-Ressource |w (DE-627)306646803 |w (DE-600)1499101-9 |w (DE-576)091142504 |x 1399-3003 |7 nnas |a Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension a phase II study |
| 773 | 1 | 8 | |g volume:36 |g year:2010 |g number:4 |g pages:792-799 |g extent:8 |a Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension a phase II study |
| 856 | 4 | 0 | |u https://doi.org/10.1183/09031936.00182909 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://erj.ersjournals.com/content/36/4/792 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230307 | ||
| 993 | |a Article | ||
| 994 | |a 2010 | ||
| 998 | |g 114011516 |a Meyer, Franz Joachim |m 114011516:Meyer, Franz Joachim |d 50000 |e 50000PM114011516 |k 0/50000/ |p 4 | ||
| 999 | |a KXP-PPN1838485767 |e 4284417851 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"name":{"displayForm":["European Respiratory Society"]},"recId":"306646803","title":[{"title":"The European respiratory journal","subtitle":"flagship scientific journal of ERS","title_sort":"European respiratory journal"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["306646803"],"issn":["1399-3003"],"zdb":["1499101-9"]},"origin":[{"publisher":"ERS ; Munksgaard","dateIssuedDisp":"1988-","dateIssuedKey":"1988","publisherPlace":"Lausanne ; Copenhagen"}],"language":["eng"],"part":{"extent":"8","pages":"792-799","issue":"4","text":"36(2010), 4, Seite 792-799","volume":"36","year":"2010"},"note":["Gesehen am 25.04.2025","Fortsetzung der Druck-Ausgabe"],"pubHistory":["1.1988 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension a phase II studyThe European respiratory journal","corporate":[{"role":"isb","display":"European Respiratory Society"}],"titleAlt":[{"title":"official journal of the European Society for Clinical Respiratory Physiology : ERJ"},{"title":"ERJ"}]}],"origin":[{"dateIssuedDisp":"June 07 2010","dateIssuedKey":"2010"}],"title":[{"title_sort":"Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension","title":"Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension","subtitle":"a phase II study"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"8 S."}],"id":{"doi":["10.1183/09031936.00182909"],"eki":["1838485767"]},"person":[{"role":"aut","family":"Ghofrani","display":"Ghofrani, Hossein Ardeschir","given":"Hossein Ardeschir"},{"family":"Höper","role":"aut","given":"Marius","display":"Höper, Marius"},{"role":"aut","family":"Halank","given":"Michael","display":"Halank, Michael"},{"display":"Meyer, Franz Joachim","given":"Franz Joachim","family":"Meyer","role":"aut"},{"given":"Gerd","display":"Stähler, Gerd","family":"Stähler","role":"aut"},{"role":"aut","family":"Behr","given":"J.","display":"Behr, J."},{"display":"Ewert, Ralf","given":"Ralf","family":"Ewert","role":"aut"},{"family":"Weimann","role":"aut","display":"Weimann, G.","given":"G."},{"role":"aut","family":"Grimminger","given":"Friedrich","display":"Grimminger, Friedrich"}],"recId":"1838485767","note":["Gesehen am 07.03.2023"],"language":["eng"],"name":{"displayForm":["H.A. Ghofrani, M.M. Hoeper, M. Halank, F.J. Meyer, G. Staehler, J. Behr, R. Ewert, G. Weimann and F. Grimminger, on behalf of the study investigators"]}} | ||
| SRT | |a GHOFRANIHORIOCIGUATF0720 | ||